Skip to main content
Clinical Trials/NCT03293953
NCT03293953
Unknown
Not Applicable

Prospective Comparison Between Transient Elastography (TE), Shear Wave Elastography (SWE) and Magnetic Resonance Elastography (MRE) for Non-invasive Assessment of Liver Fibrosis in Patients Affected by Chronic Viral Hepatitis

Ente Ospedaliero Ospedali Galliera1 site in 1 country100 target enrollmentMay 1, 2017
ConditionsLiver Fibrosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Fibrosis
Sponsor
Ente Ospedaliero Ospedali Galliera
Enrollment
100
Locations
1
Primary Endpoint
liver stiffness
Last Updated
8 years ago

Overview

Brief Summary

The main purpose of the present study is to compare the diagnostic performance of three non-invasive stiffness imaging methods (TE, SWE and MRE) in a consecutive cohort of patients with chronic viral C hepatitis or co-infected by HCV+ Human Human Immunodeficiency Virus (HIV).

Detailed Description

Primary Endpoint: Verify if Transient Elastography, Shear Wave Elastography, Magnetic Resonance Elastography (MRE) get comparable results in the measurement of liver fibrosis Secondary Endpoint: To evaluate if the level of liver iron overload and steatosis may act as a confounding factor in stiffness measurements by MRE. Tertiary Endpoint: to provide information about the prevalence and grade of steatosis in a consecutive cohort of patients with chronic viral C hepatitis, and to verify if the presence and grade of parenchymal steatosis may affect the correlation between the different non-invasive stiffness imaging modalities. Subject: consecutive 100 patients affected by chronic viral C hepatitis or co-infected by HCV+ Human Human Immunodeficiency Virus (HIV).

Registry
clinicaltrials.gov
Start Date
May 1, 2017
End Date
November 1, 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gian Andrea Rollandi

Direttore medico responsabile S.C. Radiodiagnostica

Ente Ospedaliero Ospedali Galliera

Eligibility Criteria

Inclusion Criteria

  • enrollment of a consecutive cohort of at least 100 patients affected by chronic C virus hepatitis (HCV) or co-infected by HCV+ Human Immunodeficiency Virus (HIV).

Exclusion Criteria

  • contraindications to undergo MRI examination. Impossibility to obtain a valid TE measurement (e.g. narrow intercostal spaces; obese patients)

Outcomes

Primary Outcomes

liver stiffness

Time Frame: 18 months

liver stiffness is indicated in kPa

Secondary Outcomes

  • liver steatosis(18 months)
  • liver iron overload(18 months)

Study Sites (1)

Loading locations...

Similar Trials